Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya
Stoute, José A, Gombe, Joash, Withers, Mark R, Siangla, Joram, McKinney, Denise, Onyango, Melanie, Cummings, James F, Milman, Jessica, Tucker, Kathryn, Soisson, Lorraine, Stewart, V. Ann, Lyon, Jeffrey A, Angov, Evelina, Leach, Amanda, Cohen, Joe, Kester, Kent E, Ockenhouse, Christian F, Holland, Carolyn A, Diggs, Carter L, Wittes, Janet, Gray Heppner, D
Published in Vaccine (02.01.2007)
Published in Vaccine (02.01.2007)
Get full text
Journal Article
Phase 1 randomized double-blind safety and immunogenicity trial ofPlasmodium falciparummalaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya
Stoute, José A, Gombe, Joash, Withers, Mark R, Siangla, Joram, McKinney, Denise, Onyango, Melanie, Cummings, James F, Milman, Jessica, Tucker, Kathryn, Soisson, Lorraine, Stewart, V Ann, Lyon, Jeffrey A, Angov, Evelina, Leach, Amanda, Cohen, Joe, Kester, Kent E, Ockenhouse, Christian F, Holland, Carolyn A, Diggs, Carter L, Wittes, Janet, Gray Heppner, D
Published in Vaccine (02.01.2007)
Published in Vaccine (02.01.2007)
Get full text
Journal Article